Insights - This morning the Biden administration unveiled the first 10 drugs that are going to be subject to price “negotiations” between manufacturers and Medicare, according to the Inflation … Continue Reading
Read nowEducation - Cancer companies usually accompany data readouts, conference posters or presentations with various types of graphs and plots to represent the outcomes. This note will go … Continue Reading
Read nowTranscripts - Operator Good day, and thank you for standing by. Welcome to today’s discussion with BridgeBio, which will cover the company’s accurate CM Phase III results … Continue Reading
Read nowDigital Conferences - Replay </div><script></script> Transcript of Call: Participants Mike Kelly, NervGen CEO Dan Mikol, NervGen CMO Rich Macary, KOL Deniel Mero, PropThink Editor PropThink Good morning everyone, … Continue Reading
Read nowInsights - Medtronic announced better than expected Q1 fiscal year 2024 results yesterday. The diabetes segment of the business generated quarterly sales of $578M, more than 6% … Continue Reading
Read nowResearch - In the last 3 trading days, preferred shares of Fortress Bio (FBIOP) have traded down 53% from ~$17 to ~$8. The decline seems to be … Continue Reading
PremiumInterviews - Mitra Ramgopal Okay, good afternoon, everyone, and welcome to the Sidoti August Microcap Virtual Investor Conference. My name is Mitra Ramgopal. I’m happy to be … Continue Reading
Read now
